Association between ABO and Rh Blood Groups and Risk of Preeclampsia: A Case-Control Study from Iran
DOI:
https://doi.org/10.3889/oamjms.2017.002Keywords:
ABO, Rh, Blood group, PreeclampsiaAbstract
AIM: Preeclampsia (PE) is a major cause of maternal and neonatal morbidity and mortality. There is a genetic component in the development of PE with estimated heritability around 0.47. Several studies have investigated the association between maternal ABO blood groups (OMIM: 110300) and risk of PE, with contradictory results have emerged. Considering that there is no study in this filed from Iranian population, the present case-control study was carried out at Shiraz (south-west Iran).
MATERIAL AND METHODS: In this study 331 women; 121 pregnant with PE and 210 normotensive pregnant women were included. Using blood group O (for ABO blood groups) or Rh+ (for Rh blood groups) as a reference, odds ratios (ORs) and its 95% confidence intervals (95% CI) of PE risk were estimated from logistic regression analysis.
RESULTS: Although the A (OR = 0.67, 95% CI = 0.39-1.17, P = 0.165), B (OR = 0.86, 95% CI = 0.48-1.53, P = 0.615) and AB (OR = 1.14, 95% CI = 0.37-3.45, P = 0.812) phenotypes showed lower risks compared with the O blood group, statistical analysis indicated that there was no significant association between ABO phenotypes and risk of PE. The frequency of Rh- phenotype was higher among PE patients compared with the control group. However, the association was not significant (OR = 1.79, 95% CI = 0.69-4.65, P = 0.229). Adjusted ORs for age of participants and parity did not change the above-mentioned associations.
CONCLUSION: Our present findings indicate that there is no association between ABO and Rh blood groups and risk of PE in Iranian population.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Payne B, Magee LA, von Dadelszen P. Assessment, surveillance and prognosis in pre-eclampsia. Best Pract. Res. Clin. Obstet. Gynaecol. 2011;25:449-462. https://doi.org/10.1016/j.bpobgyn.2011.02.003 PMid:21459048 DOI: https://doi.org/10.1016/j.bpobgyn.2011.02.003
Nilsson E, Salonen Ros H, Cnattingius S, Lichtenstein P. The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: a family study. BJOG. 2004;111:200-206. https://doi.org/10.1111/j.1471-0528.2004.00042x.x PMid:14961879 DOI: https://doi.org/10.1111/j.1471-0528.2004.00042x.x
Thorup J, Nordenskjöld A, Hutson JM. Genetic and environmental origins of hypospadias. Curr Opin Endocrinol Diabetes Obes. 2014;21:227-232. https://doi.org/10.1097/MED.0000000000000063 PMid:24722170 DOI: https://doi.org/10.1097/MED.0000000000000063
Petry CJ, Beardsall K, Dunger DB. The potential impact of the fetal genotype on maternal blood pressure during pregnancy. J Hypertens. 2014;32:1553-1561. https://doi.org/10.1097/HJH.0000000000000212 PMid:24842698 DOI: https://doi.org/10.1097/HJH.0000000000000212
Laivuori H, Lahermo P, Ollikainen V, Widen E, Haiva-Mallinen L, Sundstrom H, Laitinen T, Kaaja R, Ylikorkala O, Kere J. Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet. 2003;72:168-177. https://doi.org/10.1086/345311 PMid:12474145 PMCid:PMC378622 DOI: https://doi.org/10.1086/345311
Arngrimsson R, Siguroardottir S, Frigge ML, Bjarnadottir RI, Jonsson T, Stefansson H, Baldursdottir A, Einarsdottir AS, Palsson B, Snorradottir S, Lachmeijer AMA, Nicolae D, Kong A, Bragason BT, Gulcher JR, Geirsson RT, Stefansson K. A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13. Hum Mol Genet. 1999;8:1799-1805. https://doi.org/10.1093/hmg/8.9.1799 PMid:10441346 DOI: https://doi.org/10.1093/hmg/8.9.1799
Anvar Z, Namavar-Jahromi B, Saadat M. Association between consanguineous marriages and risk of pre-eclampsia. Arch Gynecol Obstet. 2011;283 Suppl 1:5-7. https://doi.org/10.1007/s00404-010-1528-8 PMid:20517614 DOI: https://doi.org/10.1007/s00404-010-1528-8
Ferguson-Smith MA, Aitken DA, Turleau C, de Grouchy J. Localisation of the human ABO: Np-1: AK-1 linkage group by regional assignment of AK-1 to 9q34. Hum Genet. 1976;34: 35-43. https://doi.org/10.1007/BF00284432 PMid:184030 DOI: https://doi.org/10.1007/BF00284432
Storry JR, Olsson ML. The ABO blood group system revisited: a review and update. Immnunochemistry. 2009;25:48-49. DOI: https://doi.org/10.21307/immunohematology-2019-231
Liumbruno GM, Franchini M. Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus. 2013;11:491-499. PMid:24120598 PMCid:PMC3827391
He M, Wolpin B, Rexrode K, Manson JE, Rimm E, Hu FB, Qi L. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol. 2012;32:2314-2320. https://doi.org/10.1161/ATVBAHA.112.248757 PMid:22895671 PMCid:PMC3488453 DOI: https://doi.org/10.1161/ATVBAHA.112.248757
Liumbruno GM, Franchini M. Hemostasis, cancer, and ABO blood group: the most recent evidence of association. J Thromb Thrombolysis. 2014;38:160-166. https://doi.org/10.1007/s11239-013-1027-4 PMid:24233389 DOI: https://doi.org/10.1007/s11239-013-1027-4
Naljayan MV, Karumanchi SA. New developments in the pathogenesis of preeclampsia. Adv Chronic Kidney Dis. 2013;20:265-270. https://doi.org/10.1053/j.ackd.2013.02.003 PMid:23928392 PMCid:PMC4107338 DOI: https://doi.org/10.1053/j.ackd.2013.02.003
Wang X, Bai T, Liu S, Pan H, Wang B. Association between thrombophilia gene polymorphisms and preeclampsia: a meta-analysis. PLoS One. 2014;9:e100789. https://doi.org/10.1371/journal.pone.0100789 PMid:24967675 PMCid:PMC4072713 DOI: https://doi.org/10.1371/journal.pone.0100789
Spinillo A, Capuzzo E, Baltaro F, Piazzi G, Iasci A. Case-control study of maternal blood group and severe preeclampsia. J Hum Hypertens. 1995;9:623-625. PMid:8523376
Witsenburg C, Rosendaal F, Middledorp J, Van der Meer FJ, Scherjon SA. Factor VIII levels and the risk of pre-eclampsia, HELLP syndrome, pregnancy related hypertension and severe intrauterine growth retardation. Thromb Res. 2005;115:387-392. https://doi.org/10.1016/j.thromres.2004.09.009 PMid:15733972 DOI: https://doi.org/10.1016/j.thromres.2004.09.009
Clark P, Walker I, Govan L, Wu O, Greer IA. The GOAL study: a prospective examination of the impact of factor V Leide and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J Haematol. 2008;140:236-240. PMid:18028481
Hiltunen LM, Laivuori H, Rautanen A, Kaaja R, Kere J, Krusius T, Paunio M, Rasi V. Blood group AB and factor V Leiden as risk factors for pre-eclampsia: a population-based nested case-control study. Thromb Res. 2009;124:167-173. https://doi.org/10.1016/j.thromres.2008.11.012 PMid:19110300 DOI: https://doi.org/10.1016/j.thromres.2008.11.012
Lee BK, Zhang Z, Wikman A, Lindqvist PG, Reilly M. ABO and RhD blood groups and gestational hypertensive disorders: a population based cohort study. BJOG. 2012;119:1232-1237. https://doi.org/10.1111/j.1471-0528.2012.03421.x PMid:22734590 DOI: https://doi.org/10.1111/j.1471-0528.2012.03421.x
Phaloprakarn C, Tangjitgamol S. Maternal ABO blood group and adverse pregnancy outcomes. J Perinatol. 2013;33:107-111. https://doi.org/10.1038/jp.2012.73 PMid:22678143 DOI: https://doi.org/10.1038/jp.2012.73
Elmugabil A, Rayis DA, Ahmed MA, Adam I, Gasim GI. O Blood Group as Risk Factor for Preeclampsia among Sudanese Women. Open Access Maced J Med Sci. 2016; 4(4):603-606. https://doi.org/10.3889/oamjms.2016.108 PMid:28028398 PMCid:PMC5175506 DOI: https://doi.org/10.3889/oamjms.2016.108
Rafiee L, Saadat I, Saadat M. Glutathione S-transferase genetic polymorphisms (GSTM1, GSTT1 and GSTO2) in three Iranian populations. Mol Biol Rep. 2010;37:155-158. https://doi.org/10.1007/s11033-009-9565-8 PMid:19430957 DOI: https://doi.org/10.1007/s11033-009-9565-8
Saadat M. Distribution of ACE insertion/deletion (I/D) polymorphism in Iranian populations. Mol Biol Res Commun. 2015;4:63-66. PMid:27843997 PMCid:PMC5019291
Fallahzadeh-Abarghooei L, Zahedi T, Mirabedi F, Saadat M. Alleleic prevalence of intron 3 insertion/deletion genetic polymorphism of DNA double-strand break repair gene XRCC4 in four Iranian populations. Egypt J Med Hum Genet. 2015;16:215-218. https://doi.org/10.1016/j.ejmhg.2015.02.004 DOI: https://doi.org/10.1016/j.ejmhg.2015.02.004
Saadat M. Estimation of allelic frequencies for ABO and Rh blood groups. Egypt J Med Hum Genet. 2016;16:205-206. https://doi.org/10.1016/j.ejmhg.2015.01.001 DOI: https://doi.org/10.1016/j.ejmhg.2015.01.001
Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30 Suppl A:S32-37. DOI: https://doi.org/10.1016/j.placenta.2008.11.009
Than NG, Romero R, Meiri H, Erez O, Xu Y, Tarquini F, Barna L, Szilagyi A, Ackerman R, Sammar M, Fule T, Karaszi K, Kovalszky I, Dong Z, Kim CJ, Zavodszky P, Papp Z, Gonen R. PP13, maternal ABO blood groups and the risk assessment of pregnancy complications. PLoS One. 2011;6:e21564. https://doi.org/10.1371/journal.pone.0021564 PMid:21799738 PMCid:PMC3143125 DOI: https://doi.org/10.1371/journal.pone.0021564
Saadat M. Apolipoprotein E (APOE) polymorphisms and susceptibility to breast cancer: A meta-analysis. Cancer Res Treat. 2012;44:121-126. https://doi.org/10.4143/crt.2012.44.2.121 PMid:22802750 PMCid:PMC3394861 DOI: https://doi.org/10.4143/crt.2012.44.2.121
Saadat M. Haplotype analysis of XRCC1 (at codons 194 and 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res Treat. 2010;124:785-791. https://doi.org/10.1007/s10549-010-0895-y PMid:20411322 DOI: https://doi.org/10.1007/s10549-010-0895-y
Saadat M, Ansari-Lari M. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res Treat. 2009;115:137-144. https://doi.org/10.1007/s10549-008-0051-0 PMid:18481169 DOI: https://doi.org/10.1007/s10549-008-0051-0
Loh M, Koh KX, Yeo BH, Song CM, Chia KS, Zhu F, Yeoh KG, Hill J, Iacopetta B, Soong R. Meta-analysis of genetic polymorphisms and gastric cancer risk: Variability in associations according to race. Eur J Cancer. 2009;45:2562-2568. https://doi.org/10.1016/j.ejca.2009.03.017 PMid:19375306 DOI: https://doi.org/10.1016/j.ejca.2009.03.017
Saadat M. Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci 2006;97:505-509. https://doi.org/10.1111/j.1349-7006.2006.00207.x PMid:16734729 DOI: https://doi.org/10.1111/j.1349-7006.2006.00207.x
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
